Neuropace Inc
NPCE
$14.90+1.02%
Delayed · as of Sep 7, 2026, 10:47 AM ET
Mkt cap
$312.24M
EV/Sales
3.49
P/E ratio
N/A
FY2025 Revenue
$99.99M
EPS (TTM)
$-0.57
Gross Margin (FY2025)
77.23%
Profit Margin (FY2025)
-21.47%
Beta
2.04
Div yield
N/A
Sector
Healthcare
Neuropace Inc (NPCE) is a medical devices company listed on US.
Latest reported NPCE revenue for 2025-12-31 was $100.0M. Net income was -$21.5M. Revenue was up 25.1% from 2024-12-31 to 2025-12-31. NPCE currently screens at market cap $312.2M.
Use this NPCE research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full NPCE income, balance, and cash tables.
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
Neuropace Inc (NPCE) is a medical devices company in the Healthcare sector.
Latest cached Neuropace Inc (NPCE) revenue for Dec 31, 2025 was $100.0M. Net income was -$21.5M. Statements: https://lician.com/financials/npce
Neuropace Inc (NPCE) market capitalization is $312.2M on the latest cached snapshot.
Neuropace Inc (NPCE) cached previous close $14.75; day range $14.47 – $14.90; volume 92,320. Session quote: https://lician.com/quote/npce
Neuropace Inc (NPCE) latest cached earnings event is "NPCE earnings" on Aug 11, 2026. Earnings calendar: https://lician.com/earnings
The latest cached NPCE filing is 8-K · Jul 28, 2026. Filings: https://lician.com/sec/npce